Clinical Trials List
2023-11-09 - 2032-11-22
Phase III
Not yet recruiting5
Recruiting2
ICD-10K74.4
Secondary biliary cirrhosis
ICD-10K75.81
Nonalcoholic steatohepatitis (NASH)
ICD-10K76.0
Fatty (change of) liver, not elsewhere classified
ICD-10K76.89
Other specified diseases of liver
ICD-10R16.2
Hepatomegaly with splenomegaly, not elsewhere classified
ICD-9571.8
Other chronic nonalcoholic liver disease
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chen-Hua Liu 無
- 洪俊銘 無
- 楊宏志 無
- Shih-Jer Hsu 無
- Chun-Jen Liu 無
- 曾岱宗 無
- 吳志宏 無
- 蘇東弘 無
- Tiffany Ting-Fang Shih 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 邱彥程 無
- Chiu Hung Chiu 無
- 簡世杰 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chun-Yen Lin 無
- 劉彥君 無
- 戴達英 無
- 林伯庭 無
- 陳博煥 無
- 鄭雅婷 無
- Chung-Wei Su 無
- 李晏榮 無
- 陳怡文 無
- Wen-Juei Jeng 無
- Rong-Nan Chien 無
- 吳季桓 無
- Tony Kuo 無
- 滕威 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
1650 participants
